PFE

Why Fidelity National Information Services (FIS), Pfizer Inc. (PFE) and Yelp Inc (YELP) Are 3 of Today’s Best Stocks

Although stocks suffered Tuesday, FIS, PFE and YELP had tailwinds on their way to joining the best-stocks-of-the-day club. More 

Is Pfizer Inc. Finally Safe To Buy Again? (PFE)

A first-quarter earnings and revenue beat has investors excited once again with formerly beat-down Pfizer Inc. Is now the time to buy PFE? More 

Tuesday’s Vital Data: Baidu Inc (ADR) (BIDU), Pfizer Inc. (PFE) and Valeant Pharmaceuticals Intl Inc (VRX)

Baidu (BIDU) put options pile on Chinese investigation, Pfizer (PFE) calls slip ahead of earnings and Valeant Pharmaceuticals (VRX) dives on investor commentary. More 

3 Great ETFs for a Biotech Rebound – BBP CNCR XBI

Biotech stocks and ETFs have recently been rebounding in impressive fashion. Tactical investors might want to take a look at BBP, XBI and CNCR. More 

Pfizer Inc.: Why PFE Stock Isn’t as Wild as It Seems

Pfizer (PFE) is going to unveil its first quarter numbers Tuesday morning, and more volatility is likely to be in the cards. More 

The Top 10 S&P 500 Dividend Stocks to Buy Now

These are the top 10 dividend stocks to buy from the S&P 500 index thanks to both big yields and a chance at market-beating returns. More 

3 Big Pharma Stocks to Buy, 3 to Avoid

Big Pharma stocks are under pressure as regulation threatens to curb drug prices and tax driven mergers are intercepted by the treasury. More